JACOBS LEVY EQUITY MANAGEMENT, INC

Position in ARVN — Arvinas, Inc.

CIK 884414 FLORHAM PARK, NJ

Position in ARVN

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$11,739,063

-$3,541,059 QoQ

Shares Held

1,412,643

-2.0% QoQ

Ownership

2.16%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

#11

of 198 holders

Holding Since

Jun 2023

10 quarters on record

Voting authority Sole 74% Shared 0% None 26%

Healthcare · as of Jun 30, 2026

JACOBS LEVY EQUITY MANAGEMENT, INC holds $741,570,791 across 81 Biotechnology names. ARVN ranks #13 (1.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	256,503	$159,939,880
2	RARE	Ultragenyx Pharmaceutical Inc.	2,939,719	$98,157,217
3	INCY	Incyte Corp	731,774	$82,953,900
4	CORT	Corcept Therapeutics Inc	695,532	$60,476,507
5	HALO	Halozyme Therapeutics, Inc.	322,377	$25,232,447
6	EXEL	Exelixis, Inc.	415,650	$22,615,516
7	AUPH	Aurinia Pharmaceuticals Inc.	1,231,516	$20,898,826
8	ALNY	Alnylam Pharmaceuticals, Inc.	60,986	$18,358,615

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$11,739,063	1,412,643	-2.0%	Shares	Sole	2026-08-14
2026-03-31	$15,280,122	1,441,521	+471.4%	Shares	Sole	2026-05-15
2025-12-31	$2,992,206	252,294	+13.4%	Shares	Sole	2026-02-13
2025-09-30	$1,895,529	222,480	+26.2%	Shares	Sole	2025-11-17
2025-06-30	$1,297,141	176,242	+311.7%	Shares	Sole	2025-08-14
2025-03-31	$300,526	42,810	+309.7%	Shares	Sole	2025-05-15
2024-03-31	$431,376	10,450	-77.7%	Shares	Sole	2024-05-15
2023-12-31	$1,924,682	46,761	-61.1%	Shares	Sole	2024-02-14
2023-09-30	$2,359,058	120,115	+32.2%	Shares	Sole	2023-11-17
2023-06-30	$2,255,517	90,875	—	Shares	Sole	2023-08-14
No filing history on record for this holder in this stock.